The growing popularity of Ozempic, Wegovy, and Mounjaro

Weight loss meds like Ozempic, Wegovy, and Mounjaro are getting more popular. More people are using them, and some governments are even turning to these drugs to fight obesity. In the UK, they’re even considering offering them to job seekers with obesity. But how do they work, and what are the differences?

Ozempic and Wegovy contain semaglutide, which helps people feel full for longer, leading to reduced food intake and weight loss. Mounjaro, which contains tirzepatide, targets an additional hormone, potentially resulting in even more significant weight loss.

The results are impressive: with Ozempic or Wegovy, you can lose around 15% of your body weight over two years, while Mounjaro can reach up to 20%. However, there is a downside. If you stop the medication, the weight may return. Common side effects include nausea and digestive issues. For this reason, it is crucial to use these medications under medical supervision to monitor progress and prevent weight regain after discontinuation.

The demand for these medications is huge. Not only are people with obesity using the injections, but celebrities have also embraced them. This has led to shortages and even illegal sales.

While these medications are helpful for obesity, it remains essential to maintain a healthy diet and exercise. If you’d like more information about weight loss with medications or see if it’s the right option for you, schedule a free consultation at Elysee Life via our website or call: 0858 – 200 200.

Source: The Standard